FINWIRES · TerminalLIVE
FINWIRES

Clarity Pharmaceuticals to Start Registrational Phase 3 Trial in Neuroendocrine Tumors After US FDA Meeting

By

-- Clarity Pharmaceuticals (ASX:CU6) will start a registrational phase 3 trial of copper-64-SARTATE in neuroendocrine tumors, following a successful end-of-phase meeting with the US Food and Drug Administration (FDA), according to a Thursday Australian bourse filing.

The company plans to recruit around 70 participants for the trial.

Clarity is also conducting recruitment for its registrational phase 3 positron emission tomography imaging trial of participants with high-risk prostate cancer prior to radical prostatectomy using copper-64-SAR-bisPSMA in the US and Australia, per the filing. It plans to recruit around 383 participants.

The trial will assess the diagnostic performance of copper-64-SAR-bisPSMA positron emission tomography in detecting prostate cancer within the pelvic lymph nodes, the filing said.

Clarity Pharmaceuticals' shares fell nearly 2% in recent trading on Thursday.

Related Articles

Asia

Central China Securities' Profit Surges 64% in Q1

Central China Securities (HKG:1375, SHA:601375) posted net profit attributable to shareholders of 168.7 million yuan for the first quarter, up 64% from 103 million yuan a year earlier, according to a Wednesday Hong Kong bourse filing.Shares of the brokerage were down nearly 1% in Thursday's midday trade.Earnings per share came in at 0.0363 yuan from 0.0222 yuan a year earlier.Operating income increased 34% to 537.6 million yuan from 401 million yuan in the prior-year period.

$HKG:1375$SHA:601375
Asia

RailTel Corporation Bags Order Worth INR138 Million for Supply of Computers

RailTel Corporation of India (NSE:RAILTEL, BOM:543265) has secured an order worth 138.4 million Indian rupees from the Directorate of Education, India, according to a Thursday filing to the Indian stock exchanges.The contract is for the setup of computer labs and the supply of laptops in government schools in Delhi, India, under the Directorate of Education, Government of NCT of Delhi.The project entails the supply, installation, commissioning, and comprehensive maintenance services for a period of five years for the equipment. It is scheduled for completion by April 29, 2031.The company's shares were down nearly 2% in recent trade in a weak broad market.

$BOM:543265$NSE:RAILTEL
Asia

China Longyuan Power Completes 1.8 Billion Yuan Debt Offering

China Longyuan Power (HKG:0916, SHE:001289) said it completed a 1.8 billion yuan issue of ultra short-term debentures, according to a Hong Kong bourse filing Wednesday.The power company's Hong Kong shares gained 5% in late morning trade Thursday.The debt has a term of 148 days and a coupon rate of 1.35%.Proceeds from the sale will be used to repay the company's previously issued debt.

$HKG:0916$SHE:001289